Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study

Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study

We report data from the final analysis of the Chinese subset of the GIDEON (the Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) study, which evaluated the safety and efficacy of sorafenib in Child-Pugh A, B and C patients with unresectab...

Full description

Bibliographic Details
Main Authors: Ye, Sheng-Long, Chen, Xiaoping, Yang, Jiamei, Bie, Ping, Zhang, Shuijun, Liu, Fengyong, Liu, Luming, Zhou, Jie, Dou, Kefeng, Hao, Chunyi, Shao, Guoliang, Xia, Qiang, Chen, Yajin, Yang, Jijin, Deng, Xiaxing, Liu, Yunpeng, Yuan, Yunfei, Fu, Zhiren, Nakajima, Keiko, Yip, Christina S.M., Lu, Zhengguang
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872739/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872739/

Similar Items